Autologous transplant
Sponsors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Medical College of Wisconsin, Hospital Universitario Dr. Jose E. Gonzalez, University of Illinois at Chicago, University of Colorado, Denver
Conditions
Breast CancerFollicular LymphomaHIVIschemic StrokeLymphedemaLymphomaMultiple MyelomaMultiple Myeloma, Refractory to Standard Treatment
Phase 1
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
CompletedNCT00024466
Start: 2001-04-30End: 2009-04-30Updated: 2018-09-19
Use of Stem Cells in Lymphedema Post Mastectomy
CompletedNCT01112189
Start: 2009-09-30End: 2010-09-30Updated: 2011-03-24
Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma
TerminatedNCT02043860
Start: 2014-01-10End: 2016-11-07Updated: 2019-10-14
TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)
CompletedNCT02043847
Start: 2014-01-14End: 2016-09-14Updated: 2024-11-13
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
TerminatedNCT02353572
Start: 2009-11-30End: 2011-09-30Updated: 2015-03-09
Phase 2
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
TerminatedNCT00096460
Start: 2004-08-31End: 2009-03-31Updated: 2023-01-05
Autologous Transplant in HIV Patients (BMT CTN 0803)
CompletedNCT01141712
Start: 2010-04-30End: 2016-06-30Updated: 2023-01-04